文献
J-GLOBAL ID:202202216637128793
整理番号:22A0453216
統合失調症における認知機能障害の新規治療標的としてのカリリン【JST・京大機械翻訳】
Kalirin as a Novel Treatment Target for Cognitive Dysfunction in Schizophrenia
著者 (8件):
Mould Arne W.
(Department of Psychiatry, University of Oxford, Oxford, UK)
,
Mould Arne W.
(Oxford Health NHS Foundation Trust, Oxford, UK)
,
Al-Juffali Noura
(Department of Psychiatry, University of Oxford, Oxford, UK)
,
Al-Juffali Noura
(Oxford Health NHS Foundation Trust, Oxford, UK)
,
von Delft Annette
(NIHR Oxford Biomedical Research Centre and Centre for Medicines Discovery, Nuffield Department of Medicine, University of Oxford, Oxford, UK)
,
Brennan Paul E.
(Centre for Medicines Discovery, Nuffield Department of Medicine, Alzheimer’s Research UK Oxford Drug Discovery Institute, University of Oxford, Oxford, UK)
,
Tunbridge Elizabeth M.
(Department of Psychiatry, University of Oxford, Oxford, UK)
,
Tunbridge Elizabeth M.
(Oxford Health NHS Foundation Trust, Oxford, UK)
資料名:
CNS Drugs
(CNS Drugs)
巻:
36
号:
1
ページ:
1-16
発行年:
2022年
JST資料番号:
W0642A
ISSN:
1172-7047
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
ドイツ (DEU)
言語:
英語 (EN)